1	NF-kappaB	_	NN	_	_	3	NMOD	_	_
2	transcriptional	_	JJ	_	_	3	NMOD	_	_
3	activity	_	NN	_	_	4	VMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	important	_	JJ	_	_	4	VMOD	_	_
6	in	_	IN	_	_	5	AMOD	_	_
7	regulating	_	VBG	_	_	6	PMOD	_	_
8	intracellular	_	JJ	_	_	9	NMOD	_	_
9	signaling	_	NN	_	_	7	VMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	stress	_	NN	_	_	12	NMOD	_	_
12	response	_	NN	_	_	9	COORD	_	_
13	,	_	,	_	_	12	P	_	_
14	proliferation	_	NN	_	_	12	COORD	_	_
15	,	_	,	_	_	14	P	_	_
16	survival	_	NN	_	_	14	COORD	_	_
17	,	_	,	_	_	16	P	_	_
18	differentiation	_	NN	_	_	16	COORD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	inflammation	_	NN	_	_	19	CONJ	_	_
21	[	_	(	_	_	22	P	_	_
22	8	_	CD	_	_	14	PRN	_	_
23	]	_	)	_	_	22	P	_	_
24	.	_	.	_	_	4	P	_	_
		
1	To	_	TO	_	_	9	VMOD	_	_
2	regulate	_	VB	_	_	1	IM	_	_
3	gene	_	NN	_	_	4	NMOD	_	_
4	transcription	_	NN	_	_	2	VMOD	_	_
5	,	_	,	_	_	9	P	_	_
6	NF-kappaB	_	NN	_	_	8	NMOD	_	_
7	p50/p65	_	NN	_	_	8	NMOD	_	_
8	heterodimers	_	NNS	_	_	9	VMOD	_	_
9	translocate	_	VBP	_	_	0	ROOT	_	_
10	to	_	TO	_	_	9	VMOD	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	nucleus	_	NN	_	_	10	PMOD	_	_
13	from	_	IN	_	_	9	VMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	cytoplasm	_	NN	_	_	13	PMOD	_	_
16	,	_	,	_	_	9	P	_	_
17	however	_	RB	_	_	21	VMOD	_	_
18	,	_	,	_	_	21	P	_	_
19	their	_	PRP$	_	_	20	NMOD	_	_
20	translocation	_	NN	_	_	21	VMOD	_	_
21	is	_	VBZ	_	_	9	COORD	_	_
22	not	_	RB	_	_	21	VMOD	_	_
23	sufficient	_	JJ	_	_	21	VMOD	_	_
24	to	_	TO	_	_	23	AMOD	_	_
25	activate	_	VB	_	_	24	IM	_	_
26	gene	_	NN	_	_	27	NMOD	_	_
27	transcription	_	NN	_	_	25	VMOD	_	_
28	.	_	.	_	_	9	P	_	_
		
1	Post-translational	_	JJ	_	_	2	NMOD	_	_
2	modification	_	NN	_	_	12	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	NMOD	_	_
5	heterodimers	_	NNS	_	_	3	PMOD	_	_
6	such	_	JJ	_	_	7	DEP	_	_
7	as	_	IN	_	_	2	NMOD	_	_
8	phosphorylation	_	NN	_	_	7	PMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	acetylation	_	NN	_	_	9	CONJ	_	_
11	also	_	RB	_	_	12	VMOD	_	_
12	contributes	_	VBZ	_	_	0	ROOT	_	_
13	to	_	TO	_	_	12	VMOD	_	_
14	its	_	PRP$	_	_	16	NMOD	_	_
15	transcriptional	_	JJ	_	_	16	NMOD	_	_
16	activity	_	NN	_	_	13	PMOD	_	_
17	[	_	(	_	_	18	P	_	_
18	41	_	CD	_	_	16	PRN	_	_
19	]	_	)	_	_	18	P	_	_
20	,	_	,	_	_	16	P	_	_
21	[	_	(	_	_	22	P	_	_
22	42	_	CD	_	_	16	APPO	_	_
23	]	_	)	_	_	22	P	_	_
24	,	_	,	_	_	22	P	_	_
25	[	_	(	_	_	26	P	_	_
26	43	_	CD	_	_	22	APPO	_	_
27	]	_	)	_	_	26	P	_	_
28	.	_	.	_	_	12	P	_	_
		
1	Because	_	IN	_	_	28	VMOD	_	_
2	NF-kappaB	_	NN	_	_	4	VMOD	_	_
3	constitutively	_	RB	_	_	4	VMOD	_	_
4	translocates	_	VBZ	_	_	1	SUB	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	nucleus	_	NN	_	_	5	PMOD	_	_
8	in	_	IN	_	_	4	VMOD	_	_
9	monocytic	_	JJ	_	_	10	NMOD	_	_
10	lineage	_	NN	_	_	8	PMOD	_	_
11	[	_	(	_	_	12	P	_	_
12	13	_	CD	_	_	4	PRN	_	_
13	]	_	)	_	_	12	P	_	_
14	and	_	CC	_	_	4	COORD	_	_
15	activates	_	VBZ	_	_	14	CONJ	_	_
16	gene	_	NN	_	_	17	NMOD	_	_
17	transcription	_	NN	_	_	15	VMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	survival	_	NN	_	_	18	CONJ	_	_
20	in	_	IN	_	_	17	NMOD	_	_
21	murine	_	JJ	_	_	22	NMOD	_	_
22	macrophages	_	NNS	_	_	20	PMOD	_	_
23	[	_	(	_	_	24	P	_	_
24	11	_	CD	_	_	15	PRN	_	_
25	]	_	)	_	_	24	P	_	_
26	,	_	,	_	_	28	P	_	_
27	we	_	PRP	_	_	28	VMOD	_	_
28	sought	_	VBD	_	_	0	ROOT	_	_
29	to	_	TO	_	_	28	VMOD	_	_
30	determine	_	VB	_	_	29	IM	_	_
31	how	_	WRB	_	_	33	VMOD	_	_
32	M-CSF	_	NN	_	_	33	VMOD	_	_
33	affected	_	VBD	_	_	30	VMOD	_	_
34	NF-kappaB	_	NN	_	_	36	NMOD	_	_
35	transcriptional	_	JJ	_	_	36	NMOD	_	_
36	activity	_	NN	_	_	33	VMOD	_	_
37	in	_	IN	_	_	33	VMOD	_	_
38	human	_	JJ	_	_	39	NMOD	_	_
39	MDMs	_	NNS	_	_	37	PMOD	_	_
40	and	_	CC	_	_	33	COORD	_	_
41	whether	_	IN	_	_	40	CONJ	_	_
42	this	_	DT	_	_	43	NMOD	_	_
43	activation	_	NN	_	_	44	VMOD	_	_
44	regulated	_	VBD	_	_	41	SUB	_	_
45	their	_	PRP$	_	_	46	NMOD	_	_
46	survival	_	NN	_	_	44	VMOD	_	_
47	.	_	.	_	_	28	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	present	_	JJ	_	_	3	NMOD	_	_
3	study	_	NN	_	_	4	VMOD	_	_
4	demonstrated	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	M-CSF	_	NN	_	_	7	VMOD	_	_
7	stimulated	_	VBD	_	_	5	SUB	_	_
8	PKCalpha	_	NN	_	_	9	NMOD	_	_
9	kinase	_	NN	_	_	7	VMOD	_	_
10	upstream	_	JJ	_	_	7	VMOD	_	_
11	of	_	IN	_	_	10	AMOD	_	_
12	NF-kappaB	_	NN	_	_	14	NMOD	_	_
13	transcriptional	_	JJ	_	_	14	NMOD	_	_
14	activity	_	NN	_	_	11	PMOD	_	_
15	in	_	IN	_	_	7	VMOD	_	_
16	primary	_	JJ	_	_	22	NMOD	_	_
17	human	_	JJ	_	_	22	NMOD	_	_
18	MDMs	_	NN	_	_	22	NMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	RAW	_	NN	_	_	19	CONJ	_	_
21	264.7	_	CD	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	15	PMOD	_	_
23	.	_	.	_	_	4	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	showed	_	VBD	_	_	0	ROOT	_	_
3	inhibition	_	NN	_	_	2	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	conventional	_	JJ	_	_	6	NMOD	_	_
6	PKCs	_	NNS	_	_	4	PMOD	_	_
7	by	_	IN	_	_	3	NMOD	_	_
8	PKC	_	NN	_	_	9	NMOD	_	_
9	inhibitors	_	NNS	_	_	7	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	kinase	_	NN	_	_	13	NMOD	_	_
12	deficient	_	JJ	_	_	13	NMOD	_	_
13	PKCalpha	_	NN	_	_	9	COORD	_	_
14	or	_	CC	_	_	13	COORD	_	_
15	PKCalpha	_	NN	_	_	16	NMOD	_	_
16	siRNA	_	NN	_	_	14	CONJ	_	_
17	blocked	_	VBD	_	_	2	VC	_	_
18	M-CSF-induced	_	JJ	_	_	20	NMOD	_	_
19	cell	_	NN	_	_	20	NMOD	_	_
20	survival	_	NN	_	_	17	VMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	NF-kappaB-regulated	_	JJ	_	_	24	NMOD	_	_
23	gene	_	NN	_	_	24	NMOD	_	_
24	expression	_	NN	_	_	21	CONJ	_	_
25	.	_	.	_	_	2	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	block	_	NN	_	_	3	VMOD	_	_
3	correlated	_	VBD	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	a	_	DT	_	_	6	NMOD	_	_
6	reduction	_	NN	_	_	4	PMOD	_	_
7	in	_	IN	_	_	6	NMOD	_	_
8	M-CSF-induced	_	JJ	_	_	9	NMOD	_	_
9	phosphorylation	_	NN	_	_	7	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	NF-kappaB	_	NN	_	_	12	NMOD	_	_
12	p65	_	NN	_	_	10	PMOD	_	_
13	at	_	IN	_	_	9	NMOD	_	_
14	Ser276	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	3	P	_	_
		
1	Consistent	_	JJ	_	_	11	VMOD	_	_
2	with	_	IN	_	_	1	AMOD	_	_
3	these	_	DT	_	_	4	NMOD	_	_
4	findings	_	NNS	_	_	2	PMOD	_	_
5	the	_	DT	_	_	9	NMOD	_	_
6	dominant	_	JJ	_	_	9	NMOD	_	_
7	negative	_	JJ	_	_	9	NMOD	_	_
8	PKCalpha	_	NN	_	_	9	NMOD	_	_
9	constructs	_	NNS	_	_	11	VMOD	_	_
10	also	_	RB	_	_	11	VMOD	_	_
11	inhibited	_	VBD	_	_	0	ROOT	_	_
12	NF-kappaB	_	NN	_	_	14	NMOD	_	_
13	p65	_	NN	_	_	14	NMOD	_	_
14	phosphorylation	_	NN	_	_	11	VMOD	_	_
15	at	_	IN	_	_	11	VMOD	_	_
16	Ser276	_	NN	_	_	15	PMOD	_	_
17	but	_	CC	_	_	15	COORD	_	_
18	not	_	RB	_	_	19	DEP	_	_
19	at	_	IN	_	_	17	CONJ	_	_
20	Ser536	_	NN	_	_	19	PMOD	_	_
21	resulting	_	VBG	_	_	20	APPO	_	_
22	in	_	IN	_	_	21	VMOD	_	_
23	reduced	_	VBN	_	_	26	NMOD	_	_
24	NF-kappaB	_	NN	_	_	26	NMOD	_	_
25	transcriptional	_	JJ	_	_	26	NMOD	_	_
26	activation	_	NN	_	_	22	PMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	M-CSF-induced	_	JJ	_	_	30	NMOD	_	_
29	MDM	_	NN	_	_	30	NMOD	_	_
30	survival	_	NN	_	_	27	CONJ	_	_
31	.	_	.	_	_	11	P	_	_
		
1	A	_	DT	_	_	5	NMOD	_	_
2	simplified	_	VBN	_	_	5	NMOD	_	_
3	proposed	_	JJ	_	_	5	NMOD	_	_
4	cartoon	_	NN	_	_	5	NMOD	_	_
5	model	_	NN	_	_	9	VMOD	_	_
6	in	_	IN	_	_	5	NMOD	_	_
7	Figure	_	NN	_	_	6	PMOD	_	_
8	9	_	CD	_	_	7	NMOD	_	_
9	demonstrates	_	VBZ	_	_	0	ROOT	_	_
10	that	_	IN	_	_	9	VMOD	_	_
11	M-CSF	_	NN	_	_	12	VMOD	_	_
12	induced	_	VBD	_	_	10	SUB	_	_
13	monocytes	_	NNS	_	_	12	VMOD	_	_
14	survival	_	NN	_	_	15	VMOD	_	_
15	is	_	VBZ	_	_	13	NMOD	_	_
16	regulated	_	VBN	_	_	15	VC	_	_
17	by	_	IN	_	_	16	VMOD	_	_
18	activating	_	VBG	_	_	17	PMOD	_	_
19	NF-kappaB	_	NN	_	_	21	NMOD	_	_
20	p65	_	NN	_	_	21	NMOD	_	_
21	phosphorylation	_	NN	_	_	18	VMOD	_	_
22	at	_	IN	_	_	21	NMOD	_	_
23	Ser276	_	NN	_	_	22	PMOD	_	_
24	via	_	IN	_	_	18	VMOD	_	_
25	PKC	_	NN	_	_	24	PMOD	_	_
26	.	_	.	_	_	9	P	_	_
		
1	Finally	_	RB	_	_	12	VMOD	_	_
2	,	_	,	_	_	12	P	_	_
3	in	_	IN	_	_	12	VMOD	_	_
4	a	_	DT	_	_	9	NMOD	_	_
5	NF-kappaB	_	NN	_	_	9	NMOD	_	_
6	p65-/-	_	JJ	_	_	9	NMOD	_	_
7	fibroblast	_	NN	_	_	9	NMOD	_	_
8	cell	_	NN	_	_	9	NMOD	_	_
9	line	_	NN	_	_	3	PMOD	_	_
10	,	_	,	_	_	12	P	_	_
11	we	_	PRP	_	_	12	VMOD	_	_
12	confirmed	_	VBD	_	_	0	ROOT	_	_
13	that	_	IN	_	_	12	VMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	Ser276	_	NN	_	_	16	NMOD	_	_
16	residue	_	NN	_	_	20	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	NF-kappaB	_	NN	_	_	19	NMOD	_	_
19	p65	_	NN	_	_	17	PMOD	_	_
20	is	_	VBZ	_	_	13	SUB	_	_
21	important	_	JJ	_	_	20	VMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	essential	_	JJ	_	_	22	CONJ	_	_
24	for	_	IN	_	_	23	COORD	_	_
25	PKC	_	NN	_	_	26	NMOD	_	_
26	modulation	_	NN	_	_	24	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	NF-kappaB	_	NN	_	_	29	NMOD	_	_
29	activity	_	NN	_	_	27	PMOD	_	_
30	.	_	.	_	_	12	P	_	_
		
1	More	_	RBR	_	_	2	AMOD	_	_
2	compelling	_	JJ	_	_	3	VC	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	we	_	PRP	_	_	6	VMOD	_	_
6	observed	_	VBD	_	_	4	SUB	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	similar	_	JJ	_	_	9	NMOD	_	_
9	regulation	_	NN	_	_	6	VMOD	_	_
10	between	_	IN	_	_	9	NMOD	_	_
11	two	_	CD	_	_	14	NMOD	_	_
12	different	_	JJ	_	_	14	NMOD	_	_
13	cell	_	NN	_	_	14	NMOD	_	_
14	lineages	_	NNS	_	_	10	PMOD	_	_
15	in	_	IN	_	_	14	NMOD	_	_
16	our	_	PRP$	_	_	17	NMOD	_	_
17	study	_	NN	_	_	15	PMOD	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Post-translational	_	JJ	_	_	2	NMOD	_	_
2	modification	_	NN	_	_	6	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	NMOD	_	_
5	p65	_	NN	_	_	3	PMOD	_	_
6	regulates	_	VBZ	_	_	0	ROOT	_	_
7	its	_	PRP$	_	_	11	NMOD	_	_
8	activating	_	VBG	_	_	11	NMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	repressing	_	VBG	_	_	9	CONJ	_	_
11	effects	_	NNS	_	_	6	VMOD	_	_
12	on	_	IN	_	_	6	VMOD	_	_
13	gene	_	NN	_	_	14	NMOD	_	_
14	expression	_	NN	_	_	12	PMOD	_	_
15	.	_	.	_	_	6	P	_	_
		
1	Among	_	IN	_	_	12	VMOD	_	_
2	the	_	DT	_	_	9	NMOD	_	_
3	seven	_	CD	_	_	9	NMOD	_	_
4	reported	_	VBN	_	_	9	NMOD	_	_
5	putative	_	JJ	_	_	9	NMOD	_	_
6	NF-kappaB	_	NN	_	_	9	NMOD	_	_
7	p65	_	NN	_	_	9	NMOD	_	_
8	phosphorylation	_	NN	_	_	9	NMOD	_	_
9	sites	_	NNS	_	_	1	PMOD	_	_
10	,	_	,	_	_	12	P	_	_
11	five	_	CD	_	_	12	VMOD	_	_
12	increase	_	VBP	_	_	0	ROOT	_	_
13	nuclear	_	JJ	_	_	14	NMOD	_	_
14	translocation	_	NN	_	_	12	VMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	DNA	_	NN	_	_	17	NMOD	_	_
17	binding	_	NN	_	_	14	COORD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	NF-kappaB	_	NN	_	_	21	NMOD	_	_
20	transcriptional	_	JJ	_	_	21	NMOD	_	_
21	activity	_	NN	_	_	18	CONJ	_	_
22	[	_	(	_	_	14	P	_	_
23	17	_	CD	_	_	14	NMOD	_	_
24	]	_	)	_	_	14	P	_	_
25	.	_	.	_	_	12	P	_	_
		
1	Similar	_	JJ	_	_	9	VMOD	_	_
2	to	_	TO	_	_	1	AMOD	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	finding	_	NN	_	_	2	PMOD	_	_
5	,	_	,	_	_	9	P	_	_
6	Zhong	_	NNP	_	_	9	VMOD	_	_
7	et	_	FW	_	_	6	NMOD	_	_
8	al.	_	FW	_	_	6	NMOD	_	_
9	found	_	VBD	_	_	0	ROOT	_	_
10	that	_	IN	_	_	9	VMOD	_	_
11	in	_	IN	_	_	18	VMOD	_	_
12	response	_	NN	_	_	11	DEP	_	_
13	to	_	TO	_	_	11	DEP	_	_
14	LPS	_	NN	_	_	11	PMOD	_	_
15	,	_	,	_	_	18	P	_	_
16	NF-kappaB	_	NN	_	_	17	NMOD	_	_
17	p65	_	NN	_	_	18	VMOD	_	_
18	is	_	VBZ	_	_	10	SUB	_	_
19	phosphorylated	_	VBN	_	_	18	VC	_	_
20	at	_	IN	_	_	19	VMOD	_	_
21	the	_	DT	_	_	25	NMOD	_	_
22	highly	_	RB	_	_	23	AMOD	_	_
23	conserved	_	VBN	_	_	25	NMOD	_	_
24	Ser276	_	NN	_	_	25	NMOD	_	_
25	residue	_	NN	_	_	20	PMOD	_	_
26	by	_	IN	_	_	19	VMOD	_	_
27	the	_	DT	_	_	29	NMOD	_	_
28	catalytic	_	JJ	_	_	29	NMOD	_	_
29	subunit	_	NN	_	_	26	PMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	PKA	_	NN	_	_	30	PMOD	_	_
32	[	_	(	_	_	31	P	_	_
33	16	_	CD	_	_	31	NMOD	_	_
34	]	_	)	_	_	31	P	_	_
35	.	_	.	_	_	9	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	PKA	_	NN	_	_	3	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	Ser276	_	NN	_	_	7	VMOD	_	_
7	can	_	MD	_	_	0	ROOT	_	_
8	be	_	VB	_	_	7	VC	_	_
9	phosphorylated	_	VBN	_	_	8	VC	_	_
10	by	_	IN	_	_	9	VMOD	_	_
11	MSK1	_	NN	_	_	10	PMOD	_	_
12	in	_	IN	_	_	9	VMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	nucleus	_	NN	_	_	12	PMOD	_	_
15	upon	_	IN	_	_	9	VMOD	_	_
16	TNFalpha	_	NN	_	_	17	NMOD	_	_
17	treatment	_	NN	_	_	15	PMOD	_	_
18	[	_	(	_	_	19	P	_	_
19	18	_	CD	_	_	17	PRN	_	_
20	]	_	)	_	_	19	P	_	_
21	.	_	.	_	_	7	P	_	_
		
1	Phosphorylation	_	NN	_	_	7	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	NF-kappaB	_	NN	_	_	4	NMOD	_	_
4	p65	_	NN	_	_	2	PMOD	_	_
5	at	_	IN	_	_	1	NMOD	_	_
6	Ser536	_	NN	_	_	5	PMOD	_	_
7	occurs	_	VBZ	_	_	0	ROOT	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	response	_	NN	_	_	8	DEP	_	_
10	to	_	TO	_	_	8	DEP	_	_
11	many	_	JJ	_	_	13	NMOD	_	_
12	inflammatory	_	JJ	_	_	13	NMOD	_	_
13	stimuli	_	NNS	_	_	8	PMOD	_	_
14	as	_	RB	_	_	13	COORD	_	_
15	well	_	RB	_	_	14	DEP	_	_
16	as	_	IN	_	_	14	DEP	_	_
17	kinases	_	NNS	_	_	14	CONJ	_	_
18	,	_	,	_	_	13	P	_	_
19	IKKalpha	_	NN	_	_	13	APPO	_	_
20	,	_	,	_	_	19	P	_	_
21	IKKbeta	_	NN	_	_	19	COORD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	RSK1	_	NN	_	_	22	CONJ	_	_
24	[	_	(	_	_	23	P	_	_
25	17	_	CD	_	_	23	NMOD	_	_
26	]	_	)	_	_	23	P	_	_
27	,	_	,	_	_	23	P	_	_
28	[	_	(	_	_	29	P	_	_
29	18	_	CD	_	_	23	COORD	_	_
30	]	_	)	_	_	29	P	_	_
31	,	_	,	_	_	29	P	_	_
32	[	_	(	_	_	33	P	_	_
33	19	_	CD	_	_	29	COORD	_	_
34	]	_	)	_	_	33	P	_	_
35	,	_	,	_	_	33	P	_	_
36	[	_	(	_	_	37	P	_	_
37	20	_	CD	_	_	33	COORD	_	_
38	]	_	)	_	_	37	P	_	_
39	,	_	,	_	_	23	P	_	_
40	[	_	(	_	_	41	P	_	_
41	21	_	CD	_	_	23	PRN	_	_
42	]	_	)	_	_	41	P	_	_
43	.	_	.	_	_	7	P	_	_
		
1	Notably	_	RB	_	_	13	VMOD	_	_
2	,	_	,	_	_	13	P	_	_
3	in	_	IN	_	_	13	VMOD	_	_
4	addition	_	NN	_	_	3	DEP	_	_
5	to	_	TO	_	_	3	DEP	_	_
6	phosphorylating	_	VBG	_	_	3	PMOD	_	_
7	Ser276	_	NN	_	_	6	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	NF-kappaB	_	NN	_	_	8	PMOD	_	_
10	,	_	,	_	_	13	P	_	_
11	our	_	PRP$	_	_	12	NMOD	_	_
12	study	_	NN	_	_	13	VMOD	_	_
13	revealed	_	VBD	_	_	0	ROOT	_	_
14	that	_	IN	_	_	13	VMOD	_	_
15	M-CSF	_	NN	_	_	17	VMOD	_	_
16	also	_	RB	_	_	17	VMOD	_	_
17	modulated	_	VBD	_	_	14	SUB	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	phosphorylation	_	NN	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	the	_	DT	_	_	24	NMOD	_	_
22	NF-kappaB	_	NN	_	_	24	NMOD	_	_
23	p65	_	NN	_	_	24	NMOD	_	_
24	subunit	_	NN	_	_	20	PMOD	_	_
25	at	_	IN	_	_	17	VMOD	_	_
26	Ser536	_	NN	_	_	25	PMOD	_	_
27	,	_	,	_	_	17	P	_	_
28	however	_	RB	_	_	37	VMOD	_	_
29	,	_	,	_	_	37	P	_	_
30	PKC	_	NN	_	_	31	NMOD	_	_
31	inhibitors	_	NNS	_	_	37	VMOD	_	_
32	or	_	CC	_	_	31	COORD	_	_
33	kinase	_	NN	_	_	36	NMOD	_	_
34	deficient	_	JJ	_	_	33	AMOD	_	_
35	PKCalpha	_	NN	_	_	36	NMOD	_	_
36	constructs	_	NNS	_	_	32	CONJ	_	_
37	did	_	VBD	_	_	17	COORD	_	_
38	not	_	RB	_	_	37	VMOD	_	_
39	affect	_	VB	_	_	37	VC	_	_
40	this	_	DT	_	_	42	NMOD	_	_
41	phosphorylation	_	NN	_	_	42	NMOD	_	_
42	event	_	NN	_	_	39	VMOD	_	_
43	.	_	.	_	_	13	P	_	_
		
1	Moreover	_	RB	_	_	14	VMOD	_	_
2	,	_	,	_	_	14	P	_	_
3	mutant	_	JJ	_	_	4	NMOD	_	_
4	constructs	_	NNS	_	_	14	VMOD	_	_
5	containing	_	VBG	_	_	4	APPO	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	point	_	NN	_	_	8	NMOD	_	_
8	mutation	_	NN	_	_	5	VMOD	_	_
9	at	_	IN	_	_	5	VMOD	_	_
10	Ser536	_	NN	_	_	9	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	NF-kappaB	_	NN	_	_	13	NMOD	_	_
13	p65	_	NN	_	_	11	PMOD	_	_
14	did	_	VBD	_	_	0	ROOT	_	_
15	not	_	RB	_	_	14	VMOD	_	_
16	reduce	_	VB	_	_	14	VC	_	_
17	NF-kappaB	_	NN	_	_	18	NMOD	_	_
18	activity	_	NN	_	_	16	VMOD	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	cells	_	NNS	_	_	19	PMOD	_	_
21	lacking	_	VBG	_	_	20	APPO	_	_
22	endogenous	_	JJ	_	_	24	NMOD	_	_
23	NF-kappaB	_	NN	_	_	24	NMOD	_	_
24	p65	_	NN	_	_	21	VMOD	_	_
25	,	_	,	_	_	16	P	_	_
26	while	_	IN	_	_	16	VMOD	_	_
27	the	_	DT	_	_	31	NMOD	_	_
28	NF-kappaB	_	NN	_	_	31	NMOD	_	_
29	p65	_	NN	_	_	31	NMOD	_	_
30	276S/A	_	NN	_	_	31	NMOD	_	_
31	construct	_	NN	_	_	32	VMOD	_	_
32	did	_	VBD	_	_	26	SUB	_	_
33	reduce	_	VB	_	_	32	VC	_	_
34	NF-kappaB	_	NN	_	_	35	NMOD	_	_
35	activity	_	NN	_	_	33	VMOD	_	_
36	in	_	IN	_	_	33	VMOD	_	_
37	these	_	DT	_	_	38	NMOD	_	_
38	cells	_	NNS	_	_	36	PMOD	_	_
39	.	_	.	_	_	14	P	_	_
		
1	Therefore	_	RB	_	_	9	VMOD	_	_
2	,	_	,	_	_	9	P	_	_
3	specific	_	JJ	_	_	5	NMOD	_	_
4	post-translational	_	JJ	_	_	5	NMOD	_	_
5	modification	_	NN	_	_	9	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	NF-kappaB	_	NN	_	_	8	NMOD	_	_
8	p65	_	NN	_	_	6	PMOD	_	_
9	is	_	VBZ	_	_	0	ROOT	_	_
10	likely	_	JJ	_	_	9	VMOD	_	_
11	to	_	TO	_	_	10	AMOD	_	_
12	regulate	_	VB	_	_	11	IM	_	_
13	transcriptional	_	JJ	_	_	14	NMOD	_	_
14	activation	_	NN	_	_	12	VMOD	_	_
15	in	_	IN	_	_	12	VMOD	_	_
16	response	_	NN	_	_	15	DEP	_	_
17	to	_	TO	_	_	15	DEP	_	_
18	specific	_	JJ	_	_	19	NMOD	_	_
19	stimuli	_	NNS	_	_	15	PMOD	_	_
20	[	_	(	_	_	21	P	_	_
21	15	_	CD	_	_	19	PRN	_	_
22	]	_	)	_	_	21	P	_	_
23	,	_	,	_	_	19	P	_	_
24	[	_	(	_	_	25	P	_	_
25	43	_	CD	_	_	19	NMOD	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	9	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	notable	_	JJ	_	_	2	VMOD	_	_
4	that	_	IN	_	_	2	VMOD	_	_
5	M-CSF	_	NN	_	_	6	VMOD	_	_
6	activated	_	VBD	_	_	4	SUB	_	_
7	NF-kappaB	_	NN	_	_	10	NMOD	_	_
8	p65	_	NN	_	_	10	NMOD	_	_
9	Ser276	_	NN	_	_	10	NMOD	_	_
10	phosphorylation	_	NN	_	_	6	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	transcriptional	_	JJ	_	_	13	NMOD	_	_
13	activation	_	NN	_	_	11	CONJ	_	_
14	in	_	IN	_	_	6	VMOD	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	PKCalpha-dependent	_	JJ	_	_	17	NMOD	_	_
17	manner	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	2	P	_	_
		
1	PKCalpha	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	member	_	NN	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	conventional	_	JJ	_	_	9	NMOD	_	_
8	PKC	_	NN	_	_	9	NMOD	_	_
9	family	_	NN	_	_	5	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	protein	_	NN	_	_	12	NMOD	_	_
12	kinases	_	NNS	_	_	10	PMOD	_	_
13	that	_	WDT	_	_	14	VMOD	_	_
14	are	_	VBP	_	_	4	NMOD	_	_
15	critical	_	JJ	_	_	14	VMOD	_	_
16	for	_	IN	_	_	15	AMOD	_	_
17	cell	_	NN	_	_	18	NMOD	_	_
18	growth	_	NN	_	_	16	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	differentiation	_	NN	_	_	18	COORD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	cell	_	NN	_	_	23	NMOD	_	_
23	death	_	NN	_	_	21	CONJ	_	_
24	.	_	.	_	_	2	P	_	_
		
1	PKCalpha	_	NN	_	_	3	VMOD	_	_
2	primarily	_	RB	_	_	3	VMOD	_	_
3	modulates	_	VBZ	_	_	0	ROOT	_	_
4	anti-apoptotic	_	JJ	_	_	7	NMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	proliferation	_	NN	_	_	5	CONJ	_	_
7	signals	_	NNS	_	_	3	VMOD	_	_
8	following	_	VBG	_	_	3	VMOD	_	_
9	cytokine	_	NN	_	_	10	NMOD	_	_
10	treatment	_	NN	_	_	8	PMOD	_	_
11	in	_	IN	_	_	10	NMOD	_	_
12	various	_	JJ	_	_	14	NMOD	_	_
13	cell	_	NN	_	_	14	NMOD	_	_
14	types	_	NNS	_	_	11	PMOD	_	_
15	[	_	(	_	_	16	P	_	_
16	42	_	CD	_	_	14	PRN	_	_
17	]	_	)	_	_	16	P	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Expression	_	NN	_	_	4	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	PKCalpha	_	NN	_	_	2	PMOD	_	_
4	attenuates	_	VBZ	_	_	0	ROOT	_	_
5	apoptosis	_	NN	_	_	4	VMOD	_	_
6	in	_	IN	_	_	5	NMOD	_	_
7	many	_	JJ	_	_	10	NMOD	_	_
8	different	_	JJ	_	_	10	NMOD	_	_
9	cell	_	NN	_	_	10	NMOD	_	_
10	types	_	NNS	_	_	6	PMOD	_	_
11	,	_	,	_	_	4	P	_	_
12	while	_	IN	_	_	4	VMOD	_	_
13	PKCalpha	_	NN	_	_	14	NMOD	_	_
14	inhibition	_	NN	_	_	16	VMOD	_	_
15	generally	_	RB	_	_	16	VMOD	_	_
16	potentiates	_	VBZ	_	_	12	SUB	_	_
17	apoptosis	_	NN	_	_	16	VMOD	_	_
18	[	_	(	_	_	17	P	_	_
19	42	_	CD	_	_	17	NMOD	_	_
20	]	_	)	_	_	17	P	_	_
21	.	_	.	_	_	4	P	_	_
		
1	In	_	IN	_	_	15	VMOD	_	_
2	our	_	PRP$	_	_	3	NMOD	_	_
3	studies	_	NNS	_	_	1	PMOD	_	_
4	using	_	VBG	_	_	3	APPO	_	_
5	conventional	_	JJ	_	_	7	NMOD	_	_
6	PKC	_	NN	_	_	7	NMOD	_	_
7	inhibitors	_	NNS	_	_	4	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	dominant	_	JJ	_	_	12	NMOD	_	_
10	negative	_	JJ	_	_	12	NMOD	_	_
11	PKCalpha	_	NN	_	_	12	NMOD	_	_
12	constructs	_	NNS	_	_	8	CONJ	_	_
13	,	_	,	_	_	15	P	_	_
14	PKCalpha	_	NN	_	_	15	VMOD	_	_
15	was	_	VBD	_	_	0	ROOT	_	_
16	critical	_	JJ	_	_	15	VMOD	_	_
17	in	_	IN	_	_	16	AMOD	_	_
18	M-CSF-induced	_	JJ	_	_	20	NMOD	_	_
19	macrophage	_	NN	_	_	20	NMOD	_	_
20	survival	_	NN	_	_	17	PMOD	_	_
21	by	_	IN	_	_	15	VMOD	_	_
22	inducing	_	VBG	_	_	21	PMOD	_	_
23	Ser276	_	NN	_	_	24	NMOD	_	_
24	phosphorylation	_	NN	_	_	22	VMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	NF-kappaB	_	NN	_	_	27	NMOD	_	_
27	p65	_	NN	_	_	25	PMOD	_	_
28	in	_	IN	_	_	22	VMOD	_	_
29	both	_	DT	_	_	36	NMOD	_	_
30	primary	_	JJ	_	_	36	NMOD	_	_
31	human	_	JJ	_	_	36	NMOD	_	_
32	MDMs	_	NN	_	_	36	NMOD	_	_
33	and	_	CC	_	_	32	COORD	_	_
34	Raw	_	NN	_	_	33	CONJ	_	_
35	264.7	_	CD	_	_	36	NMOD	_	_
36	cells	_	NNS	_	_	28	PMOD	_	_
37	.	_	.	_	_	15	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	also	_	RB	_	_	3	VMOD	_	_
3	demonstrated	_	VBD	_	_	0	ROOT	_	_
4	PKC	_	NN	_	_	7	NMOD	_	_
5	inhibition	_	NN	_	_	7	NMOD	_	_
6	downregulated	_	JJ	_	_	7	NMOD	_	_
7	NF-kappaB-induction	_	NN	_	_	3	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	anti-apoptotic	_	JJ	_	_	12	NMOD	_	_
11	gene	_	NN	_	_	12	NMOD	_	_
12	BCL-xL	_	NN	_	_	8	PMOD	_	_
13	.	_	.	_	_	3	P	_	_
		
1	Consistent	_	JJ	_	_	9	VMOD	_	_
2	with	_	IN	_	_	1	AMOD	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	finding	_	NN	_	_	2	PMOD	_	_
5	,	_	,	_	_	9	P	_	_
6	others	_	NNS	_	_	9	VMOD	_	_
7	reported	_	VBN	_	_	6	APPO	_	_
8	NF-kappaB	_	NN	_	_	7	VMOD	_	_
9	regulated	_	VBD	_	_	0	ROOT	_	_
10	the	_	DT	_	_	12	NMOD	_	_
11	gene	_	NN	_	_	12	NMOD	_	_
12	expression	_	NN	_	_	9	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	many	_	JJ	_	_	16	NMOD	_	_
15	anti-apoptotic	_	JJ	_	_	16	NMOD	_	_
16	proteins	_	NNS	_	_	13	PMOD	_	_
17	including	_	VBG	_	_	16	NMOD	_	_
18	other	_	JJ	_	_	21	NMOD	_	_
19	BCL-2	_	NN	_	_	21	NMOD	_	_
20	family	_	NN	_	_	21	NMOD	_	_
21	members	_	NNS	_	_	17	PMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	inhibitor	_	NN	_	_	22	CONJ	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	apoptosis	_	NN	_	_	29	NMOD	_	_
26	(	_	(	_	_	29	P	_	_
27	IAP	_	NN	_	_	29	NMOD	_	_
28	)	_	)	_	_	29	P	_	_
29	proteins	_	NNS	_	_	24	PMOD	_	_
30	which	_	WDT	_	_	31	VMOD	_	_
31	are	_	VBP	_	_	12	NMOD	_	_
32	regulators	_	NNS	_	_	31	VMOD	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	apoptosis	_	NN	_	_	33	PMOD	_	_
35	and	_	CC	_	_	31	COORD	_	_
36	function	_	VB	_	_	35	CONJ	_	_
37	upstream	_	RB	_	_	36	VMOD	_	_
38	of	_	IN	_	_	37	AMOD	_	_
39	caspases	_	NNS	_	_	38	PMOD	_	_
40	[	_	(	_	_	41	P	_	_
41	44	_	CD	_	_	39	PRN	_	_
42	]	_	)	_	_	41	P	_	_
43	.	_	.	_	_	9	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	been	_	VBN	_	_	2	VC	_	_
4	shown	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	phosphorylation	_	NN	_	_	11	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	p65	_	NN	_	_	7	PMOD	_	_
9	at	_	IN	_	_	6	NMOD	_	_
10	Ser276	_	NN	_	_	9	PMOD	_	_
11	prevents	_	VBZ	_	_	5	SUB	_	_
12	its	_	PRP$	_	_	13	NMOD	_	_
13	degradation	_	NN	_	_	11	VMOD	_	_
14	by	_	IN	_	_	13	NMOD	_	_
15	ubiquitin-mediated	_	JJ	_	_	16	NMOD	_	_
16	proteolysis	_	NN	_	_	14	PMOD	_	_
17	and	_	CC	_	_	11	COORD	_	_
18	promotes	_	VBZ	_	_	17	CONJ	_	_
19	cell	_	NN	_	_	20	NMOD	_	_
20	survival	_	NN	_	_	18	VMOD	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	HeLa	_	NN	_	_	23	NMOD	_	_
23	cells	_	NNS	_	_	21	PMOD	_	_
24	[	_	(	_	_	25	P	_	_
25	24	_	CD	_	_	18	PRN	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	13	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	BCL-xL	_	NN	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	3	PMOD	_	_
6	as	_	IN	_	_	5	NMOD	_	_
7	examined	_	VBN	_	_	6	SUB	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	this	_	DT	_	_	10	NMOD	_	_
10	study	_	NN	_	_	8	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	we	_	PRP	_	_	13	VMOD	_	_
13	are	_	VBP	_	_	0	ROOT	_	_
14	evaluating	_	VBG	_	_	13	VC	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	possibility	_	NN	_	_	14	VMOD	_	_
17	that	_	IN	_	_	16	NMOD	_	_
18	PKCalpha-regulated	_	JJ	_	_	20	NMOD	_	_
19	NF-kappaB	_	NN	_	_	20	NMOD	_	_
20	activity	_	NN	_	_	21	VMOD	_	_
21	upregulates	_	VBZ	_	_	17	SUB	_	_
22	additional	_	JJ	_	_	24	NMOD	_	_
23	anti-apoptotic	_	JJ	_	_	24	NMOD	_	_
24	genes	_	NNS	_	_	21	VMOD	_	_
25	in	_	IN	_	_	21	VMOD	_	_
26	an	_	DT	_	_	28	NMOD	_	_
27	M-CSF-dependent	_	JJ	_	_	28	NMOD	_	_
28	fashion	_	NN	_	_	25	PMOD	_	_
29	to	_	TO	_	_	28	NMOD	_	_
30	modulate	_	VB	_	_	29	IM	_	_
31	cell	_	NN	_	_	32	NMOD	_	_
32	survival	_	NN	_	_	30	VMOD	_	_
33	.	_	.	_	_	13	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	use	_	NN	_	_	10	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	inhibitors	_	NNS	_	_	3	PMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	siRNA	_	NN	_	_	5	CONJ	_	_
7	in	_	IN	_	_	2	NMOD	_	_
8	our	_	PRP$	_	_	9	NMOD	_	_
9	study	_	NN	_	_	7	PMOD	_	_
10	has	_	VBZ	_	_	0	ROOT	_	_
11	not	_	RB	_	_	10	VMOD	_	_
12	ruled	_	VBN	_	_	10	VC	_	_
13	out	_	RP	_	_	12	VMOD	_	_
14	that	_	IN	_	_	12	VMOD	_	_
15	other	_	JJ	_	_	17	NMOD	_	_
16	conventional	_	JJ	_	_	17	NMOD	_	_
17	PKCs	_	NNS	_	_	18	VMOD	_	_
18	might	_	MD	_	_	14	SUB	_	_
19	also	_	RB	_	_	18	VMOD	_	_
20	be	_	VB	_	_	18	VC	_	_
21	important	_	JJ	_	_	20	VMOD	_	_
22	in	_	IN	_	_	21	AMOD	_	_
23	M-CSF-induced	_	JJ	_	_	25	NMOD	_	_
24	NF-kappaB	_	NN	_	_	25	NMOD	_	_
25	activation	_	NN	_	_	22	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	macrophage	_	NN	_	_	28	NMOD	_	_
28	survival	_	NN	_	_	26	CONJ	_	_
29	.	_	.	_	_	10	P	_	_
		
1	In	_	IN	_	_	18	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	actions	_	NNS	_	_	3	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	PKCalpha	_	NN	_	_	8	NMOD	_	_
8	activation	_	NN	_	_	6	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	other	_	JJ	_	_	13	NMOD	_	_
11	conventional	_	JJ	_	_	13	NMOD	_	_
12	PKC	_	NN	_	_	13	NMOD	_	_
13	isoforms	_	NNS	_	_	9	PMOD	_	_
14	,	_	,	_	_	18	P	_	_
15	like	_	IN	_	_	18	VMOD	_	_
16	PKCbetaI/betaII	_	NN	_	_	15	PMOD	_	_
17	,	_	,	_	_	18	P	_	_
18	appear	_	VBP	_	_	0	ROOT	_	_
19	necessary	_	JJ	_	_	18	VMOD	_	_
20	for	_	IN	_	_	19	AMOD	_	_
21	macrophage	_	NN	_	_	22	NMOD	_	_
22	apoptosis	_	NN	_	_	20	PMOD	_	_
23	.	_	.	_	_	18	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	PKCbetaI/betaII	_	CD	_	_	3	NMOD	_	_
3	isoforms	_	NNS	_	_	4	VMOD	_	_
4	are	_	VBP	_	_	0	ROOT	_	_
5	expressed	_	VBN	_	_	4	VC	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	apoptotic	_	JJ	_	_	10	NMOD	_	_
8	U937	_	NN	_	_	10	NMOD	_	_
9	myelomonocytic	_	JJ	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	6	PMOD	_	_
11	[	_	(	_	_	12	P	_	_
12	45	_	CD	_	_	5	PRN	_	_
13	]	_	)	_	_	12	P	_	_
14	.	_	.	_	_	4	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	human	_	JJ	_	_	5	NMOD	_	_
3	myeloid	_	JJ	_	_	5	NMOD	_	_
4	cell	_	NN	_	_	5	NMOD	_	_
5	line	_	NN	_	_	13	VMOD	_	_
6	HL-525	_	CD	_	_	5	NMOD	_	_
7	which	_	WDT	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	5	NMOD	_	_
9	devoid	_	JJ	_	_	8	VMOD	_	_
10	of	_	IN	_	_	9	AMOD	_	_
11	endogenous	_	JJ	_	_	12	NMOD	_	_
12	PKCbetaII	_	NN	_	_	10	PMOD	_	_
13	is	_	VBZ	_	_	0	ROOT	_	_
14	resistant	_	JJ	_	_	13	VMOD	_	_
15	to	_	TO	_	_	14	AMOD	_	_
16	TNFalpha-induced	_	JJ	_	_	17	NMOD	_	_
17	apoptosis	_	NN	_	_	15	PMOD	_	_
18	[	_	(	_	_	19	P	_	_
19	46	_	CD	_	_	13	PRN	_	_
20	]	_	)	_	_	19	P	_	_
21	.	_	.	_	_	13	P	_	_
		
1	Re-expression	_	NN	_	_	7	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	PKCbetaII	_	NN	_	_	2	PMOD	_	_
4	in	_	IN	_	_	1	NMOD	_	_
5	HL-525	_	NN	_	_	6	NMOD	_	_
6	cells	_	NNS	_	_	4	PMOD	_	_
7	restores	_	VBZ	_	_	0	ROOT	_	_
8	their	_	PRP$	_	_	9	NMOD	_	_
9	susceptibility	_	NN	_	_	7	VMOD	_	_
10	to	_	TO	_	_	9	NMOD	_	_
11	TNFalpha-induced	_	JJ	_	_	12	NMOD	_	_
12	apoptosis	_	NN	_	_	10	PMOD	_	_
13	implying	_	VBG	_	_	7	VMOD	_	_
14	that	_	IN	_	_	13	VMOD	_	_
15	PKCbetaII	_	NN	_	_	16	VMOD	_	_
16	is	_	VBZ	_	_	14	SUB	_	_
17	pro-apoptotic	_	JJ	_	_	16	VMOD	_	_
18	and	_	CC	_	_	16	COORD	_	_
19	may	_	MD	_	_	18	CONJ	_	_
20	be	_	VB	_	_	19	VC	_	_
21	required	_	VBN	_	_	20	VC	_	_
22	to	_	TO	_	_	21	VMOD	_	_
23	induce	_	VB	_	_	22	IM	_	_
24	macrophage	_	NN	_	_	25	NMOD	_	_
25	apoptosis	_	NN	_	_	23	VMOD	_	_
26	.	_	.	_	_	7	P	_	_
		
1	Recent	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	demonstrated	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	NF-kappaB	_	NN	_	_	7	NMOD	_	_
6	transcriptional	_	JJ	_	_	7	NMOD	_	_
7	activity	_	NN	_	_	8	VMOD	_	_
8	can	_	MD	_	_	4	SUB	_	_
9	be	_	VB	_	_	8	VC	_	_
10	regulated	_	VBN	_	_	9	VC	_	_
11	by	_	IN	_	_	10	VMOD	_	_
12	phosphorylation	_	NN	_	_	11	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	17	NMOD	_	_
15	NF-kappaB	_	NN	_	_	17	NMOD	_	_
16	p65	_	NN	_	_	17	NMOD	_	_
17	subunit	_	NN	_	_	13	PMOD	_	_
18	in	_	IN	_	_	10	VMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	absence	_	NN	_	_	18	PMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	IkappaBalpha	_	NN	_	_	23	NMOD	_	_
23	degradation	_	NN	_	_	21	PMOD	_	_
24	[	_	(	_	_	25	P	_	_
25	47	_	CD	_	_	10	PRN	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	3	P	_	_
		
1	By	_	IN	_	_	8	VMOD	_	_
2	this	_	DT	_	_	3	NMOD	_	_
3	pathway	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	8	P	_	_
5	phosphorylation	_	NN	_	_	8	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	NF-kappaB	_	NN	_	_	6	PMOD	_	_
8	regulates	_	VBZ	_	_	0	ROOT	_	_
9	its	_	PRP$	_	_	10	NMOD	_	_
10	interaction	_	NN	_	_	8	VMOD	_	_
11	with	_	IN	_	_	10	NMOD	_	_
12	other	_	JJ	_	_	13	NMOD	_	_
13	components	_	NNS	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	the	_	DT	_	_	18	NMOD	_	_
16	basal	_	JJ	_	_	18	NMOD	_	_
17	transcriptional	_	JJ	_	_	18	NMOD	_	_
18	machinery	_	NN	_	_	14	PMOD	_	_
19	without	_	IN	_	_	8	VMOD	_	_
20	affecting	_	VBG	_	_	19	PMOD	_	_
21	its	_	PRP$	_	_	22	NMOD	_	_
22	capability	_	NN	_	_	20	VMOD	_	_
23	to	_	TO	_	_	22	NMOD	_	_
24	bind	_	VB	_	_	23	IM	_	_
25	DNA	_	NN	_	_	24	VMOD	_	_
26	[	_	(	_	_	25	P	_	_
27	21	_	CD	_	_	25	NMOD	_	_
28	]	_	)	_	_	25	P	_	_
29	.	_	.	_	_	8	P	_	_
		
1	Since	_	IN	_	_	17	VMOD	_	_
2	NF-kappaB	_	NN	_	_	3	VMOD	_	_
3	can	_	MD	_	_	1	SUB	_	_
4	bind	_	VB	_	_	3	VC	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	promoters	_	NNS	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	numerous	_	JJ	_	_	10	NMOD	_	_
9	gene	_	NN	_	_	10	NMOD	_	_
10	targets	_	NNS	_	_	7	PMOD	_	_
11	,	_	,	_	_	17	P	_	_
12	post-translational	_	JJ	_	_	13	NMOD	_	_
13	modification	_	NN	_	_	17	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	NF-kappaB	_	NN	_	_	16	NMOD	_	_
16	p65	_	NN	_	_	14	PMOD	_	_
17	may	_	MD	_	_	0	ROOT	_	_
18	affect	_	VB	_	_	17	VC	_	_
19	its	_	PRP$	_	_	20	NMOD	_	_
20	interaction	_	NN	_	_	18	VMOD	_	_
21	with	_	IN	_	_	20	NMOD	_	_
22	other	_	JJ	_	_	23	NMOD	_	_
23	proteins	_	NNS	_	_	21	PMOD	_	_
24	,	_	,	_	_	23	P	_	_
25	refining	_	VBG	_	_	23	NMOD	_	_
26	the	_	DT	_	_	27	NMOD	_	_
27	expression	_	NN	_	_	25	VMOD	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	gene	_	NN	_	_	30	NMOD	_	_
30	targets	_	NNS	_	_	28	PMOD	_	_
31	.	_	.	_	_	17	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	did	_	VBD	_	_	0	ROOT	_	_
3	not	_	RB	_	_	2	VMOD	_	_
4	find	_	VB	_	_	2	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	PKC	_	NN	_	_	7	VMOD	_	_
7	was	_	VBD	_	_	5	SUB	_	_
8	involved	_	VBN	_	_	7	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	IkappaBalpha	_	NN	_	_	11	NMOD	_	_
11	degradation	_	NN	_	_	9	PMOD	_	_
12	or	_	CC	_	_	11	COORD	_	_
13	NF-kappaB	_	NN	_	_	16	NMOD	_	_
14	p65	_	NN	_	_	16	NMOD	_	_
15	nuclear	_	JJ	_	_	16	NMOD	_	_
16	translocation	_	NN	_	_	12	CONJ	_	_
17	induced	_	VBN	_	_	11	APPO	_	_
18	by	_	IN	_	_	17	VMOD	_	_
19	M-CSF	_	NN	_	_	18	PMOD	_	_
20	,	_	,	_	_	5	P	_	_
21	but	_	CC	_	_	5	COORD	_	_
22	that	_	IN	_	_	21	CONJ	_	_
23	M-CSF-induced	_	JJ	_	_	24	NMOD	_	_
24	phosphorylation	_	NN	_	_	30	VMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	NF-kappaB	_	NN	_	_	27	NMOD	_	_
27	p65	_	NN	_	_	25	PMOD	_	_
28	at	_	IN	_	_	24	NMOD	_	_
29	Ser276	_	NN	_	_	28	PMOD	_	_
30	was	_	VBD	_	_	22	SUB	_	_
31	dramatically	_	RB	_	_	32	VMOD	_	_
32	reduced	_	VBN	_	_	30	VC	_	_
33	by	_	IN	_	_	32	VMOD	_	_
34	the	_	DT	_	_	37	NMOD	_	_
35	conventional	_	JJ	_	_	37	NMOD	_	_
36	PKC	_	NN	_	_	37	NMOD	_	_
37	inhibitor	_	NN	_	_	33	PMOD	_	_
38	and	_	CC	_	_	37	COORD	_	_
39	kinase	_	NN	_	_	41	NMOD	_	_
40	deficient	_	JJ	_	_	41	NMOD	_	_
41	PKCalpha	_	NN	_	_	38	CONJ	_	_
42	and	_	CC	_	_	33	COORD	_	_
43	by	_	IN	_	_	42	CONJ	_	_
44	siRNA	_	NNS	_	_	43	PMOD	_	_
45	towards	_	IN	_	_	44	NMOD	_	_
46	PKCalpha	_	NN	_	_	45	PMOD	_	_
47	.	_	.	_	_	2	P	_	_
		
1	Current	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	are	_	VBP	_	_	0	ROOT	_	_
4	underway	_	JJ	_	_	3	VMOD	_	_
5	to	_	TO	_	_	4	AMOD	_	_
6	delineate	_	VB	_	_	5	IM	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	protein	_	NN	_	_	9	NMOD	_	_
9	complexes	_	NNS	_	_	6	VMOD	_	_
10	formed	_	VBN	_	_	9	APPO	_	_
11	by	_	IN	_	_	10	VMOD	_	_
12	activated	_	VBN	_	_	13	NMOD	_	_
13	NF-kappaB	_	NN	_	_	11	PMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	other	_	JJ	_	_	17	NMOD	_	_
16	transcriptional	_	JJ	_	_	17	NMOD	_	_
17	co-activators	_	NNS	_	_	14	CONJ	_	_
18	in	_	IN	_	_	10	VMOD	_	_
19	response	_	NN	_	_	18	PMOD	_	_
20	to	_	TO	_	_	19	NMOD	_	_
21	M-CSF	_	NN	_	_	20	PMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	PKC	_	NN	_	_	24	NMOD	_	_
24	activation	_	NN	_	_	22	CONJ	_	_
25	.	_	.	_	_	3	P	_	_
		
1	Recently	_	RB	_	_	3	VMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	indicated	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	non-canonical	_	JJ	_	_	7	NMOD	_	_
7	pathway	_	NN	_	_	8	VMOD	_	_
8	was	_	VBD	_	_	4	SUB	_	_
9	activated	_	VBN	_	_	8	VC	_	_
10	during	_	IN	_	_	9	VMOD	_	_
11	human	_	JJ	_	_	13	NMOD	_	_
12	monocyte-macrophage	_	JJ	_	_	13	NMOD	_	_
13	differentiation	_	NN	_	_	10	PMOD	_	_
14	[	_	(	_	_	13	P	_	_
15	48	_	CD	_	_	13	NMOD	_	_
16	]	_	)	_	_	13	P	_	_
17	.	_	.	_	_	3	P	_	_
		
1	During	_	IN	_	_	12	VMOD	_	_
2	this	_	DT	_	_	3	NMOD	_	_
3	process	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	12	P	_	_
5	expression	_	NN	_	_	12	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	IKKalpha	_	NN	_	_	6	PMOD	_	_
8	among	_	IN	_	_	12	VMOD	_	_
9	other	_	JJ	_	_	10	NMOD	_	_
10	proteins	_	NNS	_	_	8	PMOD	_	_
11	,	_	,	_	_	12	P	_	_
12	is	_	VBZ	_	_	0	ROOT	_	_
13	elevated	_	VBN	_	_	12	VC	_	_
14	leading	_	VBG	_	_	13	VMOD	_	_
15	to	_	TO	_	_	14	VMOD	_	_
16	increased	_	VBN	_	_	22	NMOD	_	_
17	p52	_	NN	_	_	22	NMOD	_	_
18	NF-kappaB	_	NN	_	_	22	NMOD	_	_
19	(	_	(	_	_	22	P	_	_
20	relB	_	NN	_	_	22	NMOD	_	_
21	)	_	)	_	_	22	P	_	_
22	expression	_	NN	_	_	15	PMOD	_	_
23	through	_	IN	_	_	22	NMOD	_	_
24	partial	_	JJ	_	_	26	NMOD	_	_
25	proteolytic	_	JJ	_	_	26	NMOD	_	_
26	degradation	_	NN	_	_	23	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	the	_	DT	_	_	31	NMOD	_	_
29	p100	_	NN	_	_	31	NMOD	_	_
30	NF-kappaB	_	NN	_	_	31	NMOD	_	_
31	protein	_	NN	_	_	27	PMOD	_	_
32	.	_	.	_	_	12	P	_	_
		
1	Thus	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	it	_	PRP	_	_	4	VMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	possible	_	JJ	_	_	4	VMOD	_	_
6	that	_	IN	_	_	4	VMOD	_	_
7	M-CSF	_	NN	_	_	8	VMOD	_	_
8	regulates	_	VBZ	_	_	6	SUB	_	_
9	monocyte	_	NN	_	_	10	NMOD	_	_
10	survival	_	NN	_	_	8	VMOD	_	_
11	through	_	IN	_	_	8	VMOD	_	_
12	both	_	CC	_	_	18	DEP	_	_
13	the	_	DT	_	_	18	NMOD	_	_
14	canonical	_	JJ	_	_	18	NMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	non-canonical	_	JJ	_	_	15	CONJ	_	_
17	NF-kappaB	_	NN	_	_	18	NMOD	_	_
18	pathways	_	NNS	_	_	11	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	which	_	WDT	_	_	21	VMOD	_	_
21	will	_	MD	_	_	18	NMOD	_	_
22	be	_	VB	_	_	21	VC	_	_
23	a	_	DT	_	_	24	NMOD	_	_
24	focus	_	NN	_	_	22	VMOD	_	_
25	in	_	IN	_	_	24	NMOD	_	_
26	future	_	JJ	_	_	27	NMOD	_	_
27	research	_	NN	_	_	25	PMOD	_	_
28	.	_	.	_	_	4	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	previously	_	RB	_	_	3	VMOD	_	_
3	showed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	M-CSF	_	NN	_	_	6	VMOD	_	_
6	reduced	_	VBD	_	_	4	SUB	_	_
7	caspase-3	_	NN	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	-9	_	NN	_	_	8	CONJ	_	_
10	activity	_	NN	_	_	6	VMOD	_	_
11	and	_	CC	_	_	6	COORD	_	_
12	prevented	_	VBD	_	_	11	CONJ	_	_
13	monocyte	_	NN	_	_	14	NMOD	_	_
14	apoptosis	_	NN	_	_	12	VMOD	_	_
15	[	_	(	_	_	16	P	_	_
16	3	_	LS	_	_	6	VMOD	_	_
17	]	_	)	_	_	16	P	_	_
18	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	study	_	NN	_	_	3	VMOD	_	_
3	reveals	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	treatment	_	NN	_	_	18	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	monocytes	_	NNS	_	_	6	PMOD	_	_
8	with	_	IN	_	_	5	NMOD	_	_
9	conventional	_	JJ	_	_	11	NMOD	_	_
10	PKC	_	NN	_	_	11	NMOD	_	_
11	inhibitors	_	NNS	_	_	8	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	or	_	CC	_	_	11	COORD	_	_
14	overexpression	_	NN	_	_	13	CONJ	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	kinase-deficient	_	JJ	_	_	17	NMOD	_	_
17	PKCalpha	_	NN	_	_	15	PMOD	_	_
18	blocked	_	VBD	_	_	4	SUB	_	_
19	M-CSF-induced	_	JJ	_	_	21	NMOD	_	_
20	cell	_	NN	_	_	21	NMOD	_	_
21	survival	_	NN	_	_	18	VMOD	_	_
22	.	_	.	_	_	3	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	data	_	NNS	_	_	3	VMOD	_	_
3	revealed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	conventional	_	JJ	_	_	6	NMOD	_	_
6	PKCs	_	NNS	_	_	7	VMOD	_	_
7	are	_	VBP	_	_	4	SUB	_	_
8	upstream	_	JJ	_	_	7	VMOD	_	_
9	of	_	IN	_	_	8	AMOD	_	_
10	NF-kappaB	_	NN	_	_	11	NMOD	_	_
11	activation	_	NN	_	_	9	PMOD	_	_
12	in	_	IN	_	_	11	NMOD	_	_
13	response	_	NN	_	_	12	PMOD	_	_
14	to	_	TO	_	_	13	NMOD	_	_
15	M-CSF	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	7	COORD	_	_
17	mediate	_	VBP	_	_	16	CONJ	_	_
18	post-translational	_	JJ	_	_	19	NMOD	_	_
19	activation	_	NN	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	NF-kappaB	_	NN	_	_	22	NMOD	_	_
22	p65	_	NN	_	_	20	PMOD	_	_
23	by	_	IN	_	_	17	VMOD	_	_
24	phosphorylating	_	VBG	_	_	23	PMOD	_	_
25	Ser276	_	NN	_	_	24	VMOD	_	_
26	to	_	TO	_	_	24	VMOD	_	_
27	regulate	_	VB	_	_	26	IM	_	_
28	gene	_	NN	_	_	29	NMOD	_	_
29	transcription	_	NN	_	_	27	VMOD	_	_
30	and	_	CC	_	_	29	COORD	_	_
31	cell	_	NN	_	_	32	NMOD	_	_
32	survival	_	NN	_	_	30	CONJ	_	_
33	.	_	.	_	_	3	P	_	_
		
1	Thus	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	observation	_	NN	_	_	5	VMOD	_	_
5	may	_	MD	_	_	0	ROOT	_	_
6	provide	_	VB	_	_	5	VC	_	_
7	insight	_	NN	_	_	6	VMOD	_	_
8	in	_	IN	_	_	7	NMOD	_	_
9	potential	_	JJ	_	_	11	NMOD	_	_
10	therapeutic	_	JJ	_	_	11	NMOD	_	_
11	targets	_	NNS	_	_	8	PMOD	_	_
12	for	_	IN	_	_	11	NMOD	_	_
13	inflammatory	_	JJ	_	_	14	NMOD	_	_
14	diseases	_	NNS	_	_	12	PMOD	_	_
15	.	_	.	_	_	5	P	_	_
		
